A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaSTRAKA, C; PETTENGELL, R; PIELMEIER, A et al.Annals of oncology. 1994, Vol 5, pp S79-S84, issn 0923-7534, SUP1Conference Paper

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma : high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementMCLAUGHLIN, P; HAGEMEISTER, F. B; SWAN, F et al.Annals of oncology. 1994, Vol 5, pp 73-77, issn 0923-7534, SUP2Conference Paper

Is Hodgkin's disease an infectious disease?WOLF, J; DIEHL, V.Annals of oncology. 1994, Vol 5, pp S105-S111, issn 0923-7534, SUP1Conference Paper

Proliferation of Reed-Sternberg cells and variants in Hodgkin's diseaseGUPTA, R. K; LISTER, T. A; BODMER, J. G et al.Annals of oncology. 1994, Vol 5, pp S117-S119, issn 0923-7534, SUP1Conference Paper

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyHAGEMEISTER, F. B; PURUGGANAN, R; PODOLOFF, D. A et al.Annals of oncology. 1994, Vol 5, pp 59-63, issn 0923-7534, SUP2Conference Paper

The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomasJAFFE, E. S; ZARATE-OSORNO, A; KINGMA, D. W et al.Annals of oncology. 1994, Vol 5, pp S7-S11, issn 0923-7534, SUP1Conference Paper

Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangementWILLIAMS, M. E; SWERDLOW, S. H.Annals of oncology. 1994, Vol 5, pp S71-S73, issn 0923-7534, SUP1Conference Paper

Lymphokine receptors: a target for immunotherapy of lymphomasWALDMANN, T. A.Annals of oncology. 1994, Vol 5, pp S13-S17, issn 0923-7534, SUP1Conference Paper

Modern treatment of malignant lymphomas : a multidisciplinary approach ? The Kaplan memorial lectureBONADONNA, G.Annals of oncology. 1994, Vol 5, pp 5-16, issn 0923-7534, SUP2Conference Paper

Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entityKADIN, M. E.Annals of oncology. 1994, Vol 5, pp S25-S30, issn 0923-7534, SUP1Conference Paper

Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemicWEISENBURGER, D. D.Annals of oncology. 1994, Vol 5, pp S19-S24, issn 0923-7534, SUP1Conference Paper

Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhoodMURPHY, S. B.Annals of oncology. 1994, Vol 5, pp S31-S33, issn 0923-7534, SUP1Conference Paper

Early bone marrow transplantation in Hodgkin's diseaseARMITAGE, J. O.Annals of oncology. 1994, Vol 5, pp 161-163, issn 0923-7534, SUP2Conference Paper

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) TrialCHUGH, Rashmi; WATHEN, J. Kyle; BENJAMIN, Robert S et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4884-4891, issn 1078-0432, 8 p.Article

Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients : a case-controlled analysis of the EBMT Registry dataLIBERTI, G; PEARCE, R; TAGHIPOUR, G et al.Annals of oncology. 1994, Vol 5, pp 151-153, issn 0923-7534, SUP2Conference Paper

Early-stage Hodgkin's disease : long-term results with radiotherapy alone or combined radiotherapy and chemotherapyBRUSAMOLINO, E; LAZZARINO, M; CORBELLA, F et al.Annals of oncology. 1994, Vol 5, pp 101-106, issn 0923-7534, SUP2Conference Paper

High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma : the EBMT experienceSWEETENHAM, J. W; PROCTOR, S. J; BLAISE, D et al.Annals of oncology. 1994, Vol 5, pp 155-159, issn 0923-7534, SUP2Conference Paper

Hybrid LOPP/EVA is not better than LOPP alternating with EVAP : a prematurely terminated British National Lymphoma Investigation randomized trialHANCOCK, B. W; VAUGHAN HUDSON, G; BAUGHAN HUDSON, B et al.Annals of oncology. 1994, Vol 5, pp 117-120, issn 0923-7534, SUP2Conference Paper

Immunotoxins: is there a clinical value?GOTTSTEIN, C; WINKLER, U; BOHLEN, H et al.Annals of oncology. 1994, Vol 5, pp S97-S103, issn 0923-7534, SUP1Conference Paper

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphomaROHATINER, A. Z. S; FREEDMAN, A; NADLER, L et al.Annals of oncology. 1994, Vol 5, pp 143-146, issn 0923-7534, SUP2Conference Paper

Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14; 18) in a patient before and after allogeneic bone marrow transplantationMEIJERINK, J. P. P; GOVERDE, G. J; SMETSERS, T. F. C. M et al.Annals of oncology. 1994, Vol 5, pp S43-S45, issn 0923-7534, SUP1Conference Paper

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical ModelCHUGH, Rashmi; KYLE WATHEN, J; SAMUELS, Brian L et al.Journal of clinical oncology. 2009, Vol 27, Num 19, pp 3148-3153, issn 0732-183X, 6 p.Article

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyZAGONEL, V; BABARE, R; MEROLA, M. C et al.Annals of oncology. 1994, Vol 5, pp 127-132, issn 0923-7534, SUP2Conference Paper

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas : results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhCM-CSFENGELHARD, M; GERHARTZ, H; LUDWIG, W.-D et al.Annals of oncology. 1994, Vol 5, pp 123-125, issn 0923-7534, SUP2Conference Paper

Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomasREA, D; DELECLUSE, H.-J; HAMILTON-DUTOIT, S. J et al.Annals of oncology. 1994, Vol 5, pp S113-S116, issn 0923-7534, SUP1Conference Paper